Adenovirus E3 Proteins
Apoptosis Regulatory Proteins
Apoptosis
Caspases
RNA-Binding Proteins
Cell Death
Molecular Sequence Data
Cause of Death
Amino Acid Sequence
bcl-Associated Death Protein
Death
Death, Sudden, Cardiac
Proto-Oncogene Proteins c-bcl-2
Brain Death
Attitude to Death
Genes, bcl-2
Cell Survival
Proto-Oncogene Proteins
Signal Transduction
bcl-2-Associated X Protein
Receptors, Death Domain
CARD Signaling Adaptor Proteins
Lymphoma, B-Cell
Caspase 3
Translocation, Genetic
Risk Factors
Chromosomes, Human, Pair 14
Mitochondria
Colorectal Neoplasms
ras Proteins
Leucovorin
Camptothecin
Antibodies, Monoclonal, Humanized
Organoplatinum Compounds
Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. (1/660)
It has been suggested that the ratio of Bcl-2 family proapoptotic proteins to antiapoptotic proteins determines the sensitivity of leukemic cells to apoptosis. However, it is believed that Bcl-2 family proteins exert their function on apoptosis only when they target to the mitochondrial outer membrane. The vinblastine-resistant T-lymphoblastic leukemic cell line CEM/VLB100 has increased sensitivity to tumor necrosis factor-alpha (TNF-alpha)-induced cytochrome c release, mitochondrial respiratory inhibition, and consequently apoptosis, compared with parental CEM cells. However, there was no difference between the two cell lines in the expression of Bcl-2 family proteins Bcl-2, Bcl-XL, Bcl-XS, Bad, and Bax at the whole cell level, as analyzed by Western blotting. Bcl-2 mainly located to mitochondria and light membrane as a membrane-bound protein, whereas Bcl-XL was located in both mitochondria and cytosol. Similar levels of both Bcl-2 and Bcl-XL were present in the resting mitochondria of the two cell lines. Although the proapoptotic proteins Bcl-XS, Bad, and Bax were mainly located in the cytosol, CEM/VLB100 mitochondria expressed higher levels of these proapoptotic proteins. Subcellular redistribution of the Bcl-2 family proteins was detected in a cell-free system by both Western blotting and flow cytometry after exposure to TNF-alpha. The levels of Bcl-2 family proteins were not altered at the whole cell level by TNF-alpha. However, after exposure to TNF-alpha, Bax, Bad, and Bcl-XS translocated from the cytosol to the mitochondria of both cell lines. An increase in Bcl-2 levels was observed in CEM mitochondria, which showed resistance to TNF-alpha-induced cytochrome c release. By contrast, decreased mitochondrial Bcl-2 was observed in CEM/VLB100 cells, which released cytochrome c from the mitochondria and underwent apoptosis as detected by fluorescence microscopy. We conclude that mitochondrial levels of Bcl-2 family proteins may determine the sensitivity of leukemic cells to apoptosis and that, furthermore, these levels may change rapidly after exposure of cells to toxic stimuli. (+info)Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling. (2/660)
Interleukin-3 (IL-3) acts as both a growth and survival factor for many hemopoietic cells. IL-3 treatment of responsive cells leads to the rapid and transient activation of Class IA phosphoinositide-3-kinases (PI3Ks) and the serine/threonine kinase Akt/protein kinase B (PKB) and phosphorylation of BAD. Each of these molecules has been implicated in anti-apoptotic signaling in a wide range of cells. Using regulated expression of dominant-negative p85 (Deltap85) in stably transfected IL-3-dependent BaF/3 cells, we have specifically investigated the role of class IA PI3K in IL-3 signaling. The major functional consequence of Deltap85 expression in these cells is a highly reproducible, dramatic reduction in IL-3-induced proliferation. Expression of Deltap85 reduces IL-3-induced PKB phosphorylation and activation and phosphorylation of BAD dramatically, to levels seen in unstimulated cells. Despite these reductions, the levels of apoptosis observed in the same cells are very low and do not account for the reduction in IL-3-dependent proliferation we observe. These results show that Deltap85 inhibits both PKB activity and BAD phosphorylation without significantly affecting levels of apoptosis, suggesting that there are targets other than PKB and BAD that can transmit survival signals in these cells. Our data indicate that the prime target for PI3K action in IL-3 signaling is at the level of regulation of proliferation. (+info)Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. (3/660)
The Ca2+-activated protein phosphatase calcineurin induces apoptosis, but the mechanism is unknown. Calcineurin was found to dephosphorylate BAD, a pro-apoptotic member of the Bcl-2 family, thus enhancing BAD heterodimerization with Bcl-xL and promoting apoptosis. The Ca2+-induced dephosphorylation of BAD correlated with its dissociation from 14-3-3 in the cytosol and translocation to mitochondria where Bcl-xL resides. In hippocampal neurons, L-glutamate, an inducer of Ca2+ influx and calcineurin activation, triggered mitochondrial targeting of BAD and apoptosis, which were both suppressible by coexpression of a dominant-inhibitory mutant of calcineurin or pharmacological inhibitors of this phosphatase. Thus, a Ca2+-inducible mechanism for apoptosis induction operates by regulating BAD phosphorylation and localization in cells. (+info)Trophic support promotes survival of bcl-x-deficient telencephalic cells in vitro. (4/660)
Survival of immature neurons is regulated by Bcl-xL, as targeted disruption of bcl-x significantly increases cell death in vivo and in vitro. Death of cultured bcl-x-deficient and wild-type telencephalic cells can be prevented by fetal calf serum or chemically-defined medium (ITS), suggesting trophic factors in these media potentiate survival through a pathway independent of Bcl-xL. Addition of trophic factors to basal medium revealed that insulin and insulin-like growth factors (IGFs), but not other trophic factors, reduced apoptosis of wild-type and bcl-x-deficient telencephalic cells. Antibodies raised against IGF-I receptors and wortmannin both attenuated the effects of IGF-I, indicating survival was mediated by IGF-I receptors and phosphatidylinositol 3'-kinase signaling, whereas effects of ITS were only partially reduced by these agents. The survival promoting effects of ITS were reduced in cells lacking both bcl-x and bcl-2, indicating Bcl-2 plays a supportive role to Bcl-xL in maintaining telencephalic cell survival. Furthermore, the ratio of expression of the pro-apoptotic bax gene to the anti-apoptotic bcl-2 gene was reduced in bcl-x-deficient cultures grown in ITS, suggesting that the interaction between these bcl-2 family members may, in part, regulate a Bcl-xL independent survival pathway. Finally, the pro-apoptotic bad gene does not appear to play a role in these interactions as targeted disruption of bad did not alter apoptosis in telencephalic cultures. (+info)Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. (5/660)
Signaling pathways between cell surface receptors and the BCL-2 family of proteins regulate cell death. Survival factors induce the phosphorylation and inactivation of BAD, a proapoptotic member. Purification of BAD kinase(s) identified membrane-based cAMP-dependent protein kinase (PKA) as a BAD Ser-112 (S112) site-specific kinase. PKA-specific inhibitors blocked the IL-3-induced phosphorylation on S112 of endogenous BAD as well as mitochondria-based BAD S112 kinase activity. A blocking peptide that disrupts type II PKA holoenzyme association with A-kinase-anchoring proteins (AKAPs) also inhibited BAD phosphorylation and eliminated the BAD S112 kinase activity at mitochondria. Thus, the anchoring of PKA to mitochondria represents a focused subcellular kinase/substrate interaction that inactivates BAD at its target organelle in response to a survival factor. (+info)Developmental regulation of Bcl-2 family protein expression in the involuting mammary gland. (6/660)
Epithelial cells within the mammary gland undergo developmental programmes of proliferation and apoptosis during the pregnancy cycle. After weaning, secretory epithelial cells are removed by apoptosis. To determine whether members of the Bcl-2 gene family could be involved in regulating this process, we have examined whether changes in their expression occur during this developmental apoptotic program in vivo. Bax and Bcl-x were evenly expressed throughout development. However, expression of Bak and Bad was increased during late pregnancy and lactation, and the proteins were present during the time of maximal apoptotic involution. Thereafter, their levels declined. In contrast, Bcl-w was expressed in pregnancy and lactation but was downregulated at the onset of apoptosis. Bcl-2 was not detected in lactating or early involuting mammary gland. Thus, the pro-apoptotic proteins Bax, Bak and Bad, as well as the death-suppressors Bcl-x, Bcl-2 and Bcl-w, are synthesised in mouse mammary gland, and dynamic changes in the expression profiles of these proteins occurs during development. To determine if changes in Bak and Bcl-w expression could regulate mammary apoptosis, their effect on cultured mouse mammary epithelial cells was examined in transient transfection assays. Enforced expression of Bak induced rapid mammary apoptosis, which could be suppressed by coexpression of Bcl-w. In extracts of mammary tissue in vivo, Bak heterodimerized with Bcl-x whereas Bax associated with Bcl-w, but Bak/Bcl-w heterodimers were not detected. Thus, Bak and Bcl-w may regulate cell death through independent pathways. These results support a model in which mammary epithelial cells are primed for apoptosis during the transition from pregnancy to lactation by de novo expression of the death effectors Bak and Bad. It is suggested that these proteins are prevented from triggering apoptosis by anti-apoptotic Bcl-2 family proteins until involution, when the levels of Bcl-w decline. Our study provides evidence that regulated changes in the expression of cell death genes may contribute to the developmental control of mammary apoptosis. (+info)Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. (7/660)
Protein kinase B lies "downstream" of phosphatidylinositide (PtdIns) 3-kinase and is thought to mediate many of the intracellular actions of insulin and other growth factors. Here we show that FKHR, a human homologue of the DAF16 transcription factor in Caenorhabditis elegans, is rapidly phosphorylated by human protein kinase Balpha (PKBalpha) at Thr-24, Ser-256, and Ser-319 in vitro and at a much faster rate than BAD, which is thought to be a physiological substrate for PKB. The same three sites, which all lie in the canonical PKB consensus sequences (Arg-Xaa-Arg-Xaa-Xaa-(Ser/Thr)), became phosphorylated when FKHR was cotransfected with either PKB or PDK1 (an upstream activator of PKB). All three residues became phosphorylated when 293 cells were stimulated with insulin-like growth factor 1 (IGF-1). The IGF-1-induced phosphorylation was abolished by the PtdIns 3-kinase inhibitor wortmannin but not by PD 98059 (an inhibitor of the mitogen-activated protein kinase cascade) or by rapamycin. These results indicate that FKHR is a physiological substrate of PKB and that it may mediate some of the physiological effects of PKB on gene expression. DAF16 is known to be a component of a signaling pathway that has been partially dissected genetically and includes homologues of the insulin/IGF-1 receptor, PtdIns 3-kinase and PKB. The conservation of Thr-24, Ser-256, and Ser-319 and the sequences surrounding them in DAF16 therefore suggests that DAF16 is also a direct substrate for PKB in C. elegans. (+info)Cytokine-induced protein kinase B activation and Bad phosphorylation do not correlate with cell survival of hemopoietic cells. (8/660)
Activation of phosphoinositide-3 kinases (PI3Ks), their downstream target protein kinase B (PKB), and phosphorylation of Bad have all been implicated in survival signaling in many systems. However, it is not known whether these events are sufficient or necessary to universally prevent apoptosis. To address this issue, we have used three different factor-dependent hemopoietic cell lines, MC/9, BaF/3, and factor-dependent (FD)-6, which respond to a range of cytokines, to investigate the relationship between PI3K, PKB, and Bad activity with survival. The cytokines IL-3, IL-4, stem cell factor (SCF), GM-CSF, and insulin all induced the rapid and transient activation of PKB in responsive cell lines. In all cases, cytokine-induced PKB activation was sensitive to inhibition by the PI3K inhibitor, LY294002. However, dual phosphorylation of the proapoptotic protein Bad was found not to correlate with PKB activation. In addition, we observed cell-type-specific differences in the ability of the same cytokine to induce Bad phosphorylation. Whereas IL-4 induced low levels of dual phosphorylation of Bad in FD-6, it was unable to in MC/9 or BaF/3. Insulin, which was the most potent inducer of PKB in FD-6, induced barely detectable Bad phosphorylation. In addition, the ability of a particular cytokine to induce PKB activity did not correlate with its ability to promote cell survival and/or proliferation. These data demonstrate that, in hemopoietic cells, activation of PKB does not automatically confer a survival signal or result in phosphorylation of Bad, implying that other survival pathways must be involved. (+info)In medical terms, death is defined as the irreversible cessation of all bodily functions that are necessary for life. This includes the loss of consciousness, the absence of breathing, heartbeat, and other vital signs. Brain death, which occurs when the brain no longer functions, is considered a definitive sign of death.
The medical professionals use various criteria to determine death, such as:
1. Cessation of breathing: When an individual stops breathing for more than 20 minutes, it is considered a sign of death.
2. Cessation of heartbeat: The loss of heartbeat for more than 20 minutes is another indicator of death.
3. Loss of consciousness: If an individual is unresponsive and does not react to any stimuli, it can be assumed that they have died.
4. Brain death: When the brain no longer functions, it is considered a definitive sign of death.
5. Decay of body temperature: After death, the body's temperature begins to decrease, which is another indicator of death.
In some cases, medical professionals may use advanced technologies such as electroencephalography (EEG) or functional magnetic resonance imaging (fMRI) to confirm brain death. These tests can help determine whether the brain has indeed ceased functioning and if there is no hope of reviving the individual.
It's important to note that while death is a natural part of life, it can be a difficult and emotional experience for those who are left behind. It's essential to provide support and care to the family members and loved ones of the deceased during this challenging time.
Some examples of the use of 'Death, Sudden, Cardiac' in medical contexts include:
1. Sudden cardiac death (SCD) is a major public health concern, affecting thousands of people each year in the United States alone. It is often caused by inherited heart conditions, such as hypertrophic cardiomyopathy or long QT syndrome.
2. The risk of sudden cardiac death is higher for individuals with a family history of heart disease or other pre-existing cardiovascular conditions.
3. Sudden cardiac death can be prevented by prompt recognition and treatment of underlying heart conditions, as well as by avoiding certain risk factors such as smoking, physical inactivity, and an unhealthy diet.
4. Cardiopulmonary resuscitation (CPR) and automated external defibrillators (AEDs) can be effective in restoring a normal heart rhythm during sudden cardiac death, especially when used promptly after the onset of symptoms.
The committee defined "brain death" as follows:
* The absence of any clinical or electrophysiological signs of consciousness, including the lack of response to pain, light, sound, or other stimuli.
* The absence of brainstem reflexes, such as pupillary reactivity, oculocephalic reflex, and gag reflex.
* The failure of all brain waves, including alpha, beta, theta, delta, and epsilon waves, as detected by electroencephalography (EEG).
* The absence of any other clinical or laboratory signs of life, such as heartbeat, breathing, or blood circulation.
The definition of brain death is important because it provides a clear and consistent criteria for determining death in medical settings. It helps to ensure that patients who are clinically dead are not inappropriately kept on life support, and that organ donation can be performed in a timely and ethical manner.
There are different types of fetal death, including:
1. Stillbirth: This refers to the death of a fetus after the 20th week of gestation. It can be caused by various factors, such as infections, placental problems, or umbilical cord compression.
2. Miscarriage: This occurs before the 20th week of gestation and is usually due to chromosomal abnormalities or hormonal imbalances.
3. Ectopic pregnancy: This is a rare condition where the fertilized egg implants outside the uterus, usually in the fallopian tube. It can cause fetal death and is often diagnosed in the early stages of pregnancy.
4. Intrafamilial stillbirth: This refers to the death of two or more fetuses in a multiple pregnancy, usually due to genetic abnormalities or placental problems.
The diagnosis of fetal death is typically made through ultrasound examination or other imaging tests, such as MRI or CT scans. In some cases, the cause of fetal death may be unknown, and further testing and investigation may be required to determine the underlying cause.
There are various ways to manage fetal death, depending on the stage of pregnancy and the cause of the death. In some cases, a vaginal delivery may be necessary, while in others, a cesarean section may be performed. In cases where the fetus has died due to a genetic abnormality, couples may choose to undergo genetic counseling and testing to assess their risk of having another affected pregnancy.
Overall, fetal death is a tragic event that can have significant emotional and psychological impact on parents and families. It is essential to provide compassionate support and care to those affected by this loss, while also ensuring appropriate medical management and follow-up.
There are several subtypes of lymphoma, B-cell, including:
1. Diffuse large B-cell lymphoma (DLBCL): This is the most common type of B-cell lymphoma and typically affects older adults.
2. Follicular lymphoma: This type of lymphoma grows slowly and often does not require treatment for several years.
3. Marginal zone lymphoma: This type of lymphoma develops in the marginal zone of the spleen or other lymphoid tissues.
4. Hodgkin lymphoma: This is a type of B-cell lymphoma that is characterized by the presence of Reed-Sternberg cells, which are abnormal cells that can be identified under a microscope.
The symptoms of lymphoma, B-cell can vary depending on the subtype and the location of the tumor. Common symptoms include swollen lymph nodes, fatigue, fever, night sweats, and weight loss.
Treatment for lymphoma, B-cell usually involves chemotherapy, which is a type of cancer treatment that uses drugs to kill cancer cells. Radiation therapy may also be used in some cases. In some cases, bone marrow or stem cell transplantation may be recommended.
Prognosis for lymphoma, B-cell depends on the subtype and the stage of the disease at the time of diagnosis. In general, the prognosis is good for patients with early-stage disease, but the cancer can be more difficult to treat if it has spread to other parts of the body.
Prevention of lymphoma, B-cell is not possible, as the exact cause of the disease is not known. However, avoiding exposure to certain risk factors, such as viral infections and pesticides, may help reduce the risk of developing the disease. Early detection and treatment can also improve outcomes for patients with lymphoma, B-cell.
Lymphoma, B-cell is a type of cancer that affects the immune system and can be treated with chemotherapy and other therapies. The prognosis varies depending on the subtype and stage of the disease at diagnosis. Prevention is not possible, but early detection and treatment can improve outcomes for patients with this condition.
https://www.medicinenet.com › Medical Dictionary › G
A genetic translocation is a change in the number or arrangement of the chromosomes in a cell. It occurs when a portion of one chromosome breaks off and attaches to another chromosome. This can result in a gain or loss of genetic material, which can have significant effects on the individual.
Genetic Translocation | Definition & Facts | Britannica
https://www.britannica.com › science › Genetic-tr...
Genetic translocation, also called chromosomal translocation, a type of chromosomal aberration in which a portion of one chromosome breaks off and attaches to another chromosome. This can result in a gain or loss of genetic material. Genetic translocations are often found in cancer cells and may play a role in the development and progression of cancer.
Translocation, Genetic | health Encyclopedia - UPMC
https://www.upmc.com › health-library › gene...
A genetic translocation is a change in the number or arrangement of the chromosomes in a cell. It occurs when a portion of one chromosome breaks off and attaches to another chromosome. This can result in a gain or loss of genetic material, which can have significant effects on the individual.
Genetic Translocation | Genetics Home Reference - NIH
https://ghr.nlm.nih.gov › condition › ge...
A genetic translocation is a change in the number or arrangement of the chromosomes in a cell. It occurs when a portion of one chromosome breaks off and attaches to another chromosome. This can result in a gain or loss of genetic material, which can have significant effects on the individual.
In conclusion, Genetic Translocation is an abnormality in the number or arrangement of chromosomes in a cell. It occurs when a portion of one chromosome breaks off and attaches to another chromosome, resulting in a gain or loss of genetic material that can have significant effects on the individual.
The causes of colorectal neoplasms are not fully understood, but factors such as age, genetics, diet, and lifestyle have been implicated. Symptoms of colorectal cancer can include changes in bowel habits, blood in the stool, abdominal pain, and weight loss. Screening for colorectal cancer is recommended for adults over the age of 50, as it can help detect early-stage tumors and improve survival rates.
There are several subtypes of colorectal neoplasms, including adenomas (which are precancerous polyps), carcinomas (which are malignant tumors), and lymphomas (which are cancers of the immune system). Treatment options for colorectal cancer depend on the stage and location of the tumor, but may include surgery, chemotherapy, radiation therapy, or a combination of these.
Research into the causes and treatment of colorectal neoplasms is ongoing, and there has been significant progress in recent years. Advances in screening and treatment have improved survival rates for patients with colorectal cancer, and there is hope that continued research will lead to even more effective treatments in the future.
Bcl-2-associated death promoter
Bcl-2-like protein 1
Bcl-2-associated X protein
Bcl-2
Bcl-2 family
C-Raf
Venetoclax
BNIP3
MCL1
Bcl-2 homologous antagonist killer
Bcl-2-interacting killer
BNIP2
Primary pigmented nodular adrenocortical disease
BCLAF1
Sanford Burnham Prebys Medical Discovery Institute
TARBP2
Chandrima Shaha
Apoptosome
Bcl-xL
BAG3
XIAP
Phorbol-12-myristate-13-acetate-induced protein 1
HRK (gene)
Ebola viral protein 24
Major facilitator superfamily
Neuroprotection
BAG1
DAD1
HSPA1A
P53 upregulated modulator of apoptosis
Caspase-activated DNase
Galectin-9
GLI2
Erinna Lee
BCL2L13
Prostate cancer
AP-1 transcription factor
Belimumab
Nuclear receptor 4A1
Calcineurin
Anticancer gene
Unfolded protein response
Chronic lymphocytic leukemia
MicroRNA 148a
Tyrosine-protein kinase BLK
DLC1
Fas ligand
AIFM2
S100A10
Beth Levine (physician)
Forkhead box protein O1
MOAP1
CDKN1B
Giardiasis
BAG domain
P21
Glucocorticoid
BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures
The discovery from the TRAIL protein and its own death receptors - New dimension in therapeutic targeting of BCL-2 family
FITC anti-Bcl-2 Antibody anti-Bcl-2 - BCL/10C4
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax |...
Plus it
Publication Detail
Structural Biophysics | NHLBI, NIH
Figure 1 - Immune Cell Apoptosis Prevention as Potential Therapy for Severe Infections - Volume 13, Number 2-February 2007 -...
Ultrasonic Nanoemulsification of Cuminum cyminum Essential Oil and Its | IJN
New compound shows promise in treating multiple human cancers | WEHI
Biomarkers Search
Pathology Research Laboratories | Pathology
NIOSHTIC-2 Search Results - Full View
Exploring the anti-cancer and anti-inflammatory properties of isothiocyanates, News, University of Otago, Christchurch,...
Frontiers | IL-1β and TNFα Differentially Influence NF-κB Activity and FasL-Induced Apoptosis in Primary Murine Hepatocytes...
Venetoclax: First Global Approval - PubMed
MeSH Browser
Pediatric Posttransplant Lymphoproliferative Disease: Overview, Incidence, Risk Factors
Venetoclax - LiverTox - NCBI Bookshelf
2003 NIH Research Festival
NIMH » Macrophage Infection by HIV: Implications for Pathogenesis and Cure: Day One
Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer
cell death<...
NIH Director's New Innovator Award Program - 2014 Award Recipients | NIH Common Fund
Mapping of Structure-Function Peptide Sites on the Human Alpha-fetoprotein Amino Acid Sequence
Nanoparticles of Titanium and Zinc Oxides as Novel Agents in Tumor Treatment: a Review | SpringerLink
A C177536 GDC Property Terminology C104674 Genome-Wide DNA Copy Number The number of DNA sequence copies found over the entire...
Publications - Institute for Bioengineering of Catalonia
Huperzine A ameliorates damage induced by acute myocardial infarction in rats through antioxidant, anti-apoptotic and anti...
Apoptosis26
- We provide genetic evidence that BAD, a protein with dual functions in apoptosis and glucose metabolism, imparts reciprocal effects on metabolism of glucose and ketone bodies in brain cells. (nih.gov)
- Presently, inhibitors from the apoptosis protein, mobile FLICE-like R935788 inhibitory proteins (c-FLIP) and inhibitors of apoptosis proteins (IAPs, including XIAP) are believed to lead to cellular Path resistance. (colinsbraincancer.com)
- Apoptosis regulator proteins, Bcl-2 family, BH1-4 domains. (biolegend.com)
- The extrinsic pathway is mediated by a variety of death receptor ligands, including tumor necrosis factor (TNF) and Fas ligand (FaSL), that trigger apoptosis by binding to cell surface receptors. (cdc.gov)
- 3 Besides, drug resistance due to suppression of apoptosis and expressive levels of anti-apoptotic proteins has intensified in cancer treatment. (dovepress.com)
- 2. CDK1 switches mitotic arrest to apoptosis by phosphorylating Bcl-2/Bax family proteins during treatment with microtubule interfering agents. (nih.gov)
- 10. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1. (nih.gov)
- 13. MJ-29 inhibits tubulin polymerization, induces mitotic arrest, and triggers apoptosis via cyclin-dependent kinase 1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. (nih.gov)
- One of the isothiocyanates was able to trigger apoptosis in cells overexpressing Bcl-2, a protein that is present at high levels in many cancers. (otago.ac.nz)
- Venetoclax (ven et' oh klax) is a small molecule inhibitor of BCL-2, an intracellular protein that inhibits apoptosis. (nih.gov)
- Recently it has become apparent that there are multiple pathways leading to cell death besides classical caspase-mediated apoptosis. (nih.gov)
- Apoptosis and other forms of cell death are required for trimming excess, expired and damaged cells. (hopkinsmedicine.org)
- We are also investigating the contribution of neuronal/glial apoptosis and necrosis as cell death pathways in animal (including transgenic mice) models of acute and progressive neurodegeneration. (hopkinsmedicine.org)
- We also investigate several discrete mechanisms involved in cell death , including the role of nitric oxide as an endogenous messenger, the function of poly (ADP-ribose) polymerase-1 and apoptosis inducing factor in cell death , and how endogenous cell survival mechanisms protect neurons from death. (hopkinsmedicine.org)
- Emphasis is further placed upon homeodomain and apoptosis AA sequence identities given that AFP serves as a fetal, phase-specific protein throughout embryogenesis, histogenesis, and organogenesis. (atlasgeneticsoncology.org)
- In addition, proteins of the Bcl-2 family have been shown to play a central role in the regulation of cellular apoptosis. (spandidos-publications.com)
- DISCUSSION: The higher Bax: Bcl-2 ratio in preterm placenta suggests the sensitivity to apoptosis. (bvsalud.org)
- Bcl-XL is an anti-apoptotic protein which is a member of the Bcl-2 family which are able to form heterodimers, and this is an significant event in the regulation of apoptosis. (neobiolab.com)
- Bcl-xL is the leading monitor of apoptosis/active cell suicide. (neobiolab.com)
- Apoptosis is an evolutionarily conserved form of programmed cell death. (cnrs.fr)
- The ubiquitin-proteasome system plays an important role in the regulation of apoptosis by controlling the level or function of many regulatory proteins. (cnrs.fr)
- TRIM17 induces neuronal apoptosis by promoting the degradation of the anti-apoptotic protein Mcl-1 and by inhibiting the survival factor NFATc4, but also by inhibiting the degradation of pro-apoptotic proteins mediated by other E3 ubiquitin-ligases from the TRIM family: ZSCAN21 by TRIM41 and NFATc3 by TRIM39. (cnrs.fr)
- It is currently unclear whether BCL-2 inhibits autophagy as well as apoptosis in follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) which frequently express BCL-2 at high levels. (bl.uk)
- We initially found that the BCL-2 inhibitor ABT-737 concurrently induced autophagy and apoptosis in BCL-2HIGH DLBCL cell lines. (bl.uk)
- These results suggest that inhibition of BCL-2 can induce cytoprotective autophagy, but overexpression of BCL-2 alone may increase basal level autophagy by inhibiting apoptosis. (bl.uk)
- DLBCL patients with lower p62 or LC3 expression and higher levels of BCL-2, i.e. active autophagy and inhibited apoptosis, had the worst prognosis. (bl.uk)
Anti-apoptotic proteins2
- Cisplatin upregulated the expression of both death and decoy TRAIL receptors, as well as of TRAF5 and -6, downregulated the anti-apoptotic proteins, Bcl-2, and induced activation of caspases-3, -8 and -9. (nih.gov)
- Cisplatin/Apo2L/TRAIL combination resulted in further downregulation of expression of anti-apoptotic proteins, Bcl-2 and Bcl-xL, as well as an increase in mitochondrial permeability transition and activation of caspases-3, -8, and -10. (nih.gov)
Phosphorylation6
- This protein is modified by ASK1/JNK1, PKC, ERKs, and stress-activated kinase phosphorylation and can be ubiquitinated. (biolegend.com)
- 3. Critical role of anti-apoptotic Bcl-2 protein phosphorylation in mitotic death. (nih.gov)
- 6. Proteomic analysis of annexin A2 phosphorylation induced by microtubule interfering agents and kinesin spindle protein inhibitors. (nih.gov)
- 16. Role of cyclin B1/Cdc2 in mediating Bcl-XL phosphorylation and apoptotic cell death following nocodazole-induced mitotic arrest. (nih.gov)
- A pro-apoptotic protein and member of the Bcl-2 protein family that is regulated by PHOSPHORYLATION . (nih.gov)
- Upon oral administration,gartisertib selectively inhibits ATR activity and blocks the downstream phosphorylation of the serine/threonine protein kinase CHK1. (nih.gov)
Apoptotic death1
- This protein blocks apoptotic death by controlling mitochondrial membrane permeability. (biolegend.com)
MRNA2
- Semi-quantitative reverse transcriptase with polymerase chain reaction (PCR) techniques were used to determine the expression levels of pro-apoptotic factors Bad and Bax, and anti-apoptotic Bcl(2) mRNA. (nih.gov)
- The mRNA and protein expression of Bcl-2, Bax, Cyclin D1, VEGF-A and VEGFR2 was measured by RT-PCR and IHS, respectively. (biomedcentral.com)
Inhibits4
- Unphosphorylated Bad protein inhibits the activity of BCL-XL PROTEIN . (nih.gov)
- SDX7539 binds to and inhibits MetAP2, which prevents MetAP2-mediated signal transduction pathways and results in tumor cell death. (nih.gov)
- For example, we showed that TRIM17 inhibits TRIM28-mediated ubiquitination and degradation of the anti-apoptotic protein BCL2A1, thereby promoting the survival of BCL2A1-dependent cells, including chemotherapy-resistant melanoma cells (Lionnard et al. (cnrs.fr)
- TRIM17 overexpression in Neuro2A cells inhibits the interaction between the endogenous proteins TRIM39 and NFATc3 assessed by proximity ligation assay. (cnrs.fr)
Venetoclax6
- Inhibition of anti-apoptotic protein BCL-2 with venetoclax emerged as a promising strategy for this subtype of BCP-ALL, however, lack of sufficient responses in preclinical models and the possibility of developing resistance exclude using venetoclax as monotherapy. (nature.com)
- Using RNA-seq, we observed that long-term exposure to venetoclax in vivo in a patient-derived xenograft model leads to downregulation of several tumor protein 53 ( TP53 )-related genes. (nature.com)
- Venetoclax (Venclexta™) is an oral selective inhibitor of the prosurvival protein BCL-2 and therefore restores the apoptotic ability of malignant cells. (nih.gov)
- Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia. (nih.gov)
- Venetoclax is an oral selective BCL-2 inhibitor and antineoplastic agent used in the therapy of refractory chronic lymphocytic leukemia (CLL). (nih.gov)
- Venetoclax binds directly to BCL2 and blocks its antiapoptotic activity, leading to programmed cell death in the malignant B cells. (nih.gov)
Lymphoma2
- Analysis of apoptotic signalling pathways reveals that TL-77 down-regulates expression of B-cell lymphoma 2 (Bcl-2) family proteins [Bid (BH3 interacting-domain death agonist), Bcl-xl (B-cell lymphoma-extra large) and Mcl-1 (induced myeloid leukaemia cell differentiation protein)] and stimulates caspase activation. (nottingham.ac.uk)
- In summary, this study demonstrates that FL, characterised by overexpression of BCL-2, shows increased autophagy activity, indicating that BCL-2 may not inhibit basal level autophagy in this indolent lymphoma. (bl.uk)
Mitochondrial5
- Bcl-2 is distributed in the outer mitochondrial membrane, the nuclear envelope, and the endoplasmic reticulum. (biolegend.com)
- The isothiocyanate had a greater effect on mitochondrial function in cells with Bcl-2, suggesting a mechanism for how it bypasses Bcl-2 action. (otago.ac.nz)
- Interestingly, cell death regulators also regulate many other cellular processes prior to a death stimulus, including neuronal activity, mitochondrial dynamics and energetics. (hopkinsmedicine.org)
- In addition, Bcl-2 family proteins have normal physiological roles in regulating mitochondrial fission/fusion and mitochondrial energetics to facilitate neuronal activity in healthy brains. (hopkinsmedicine.org)
- Bcl-XL is a transmembrane protein located in the mitochondrial membranes of cells that are long-lived and postmitotic, such as adult brain cells. (neobiolab.com)
Cells17
- The discovery from the TRAIL protein and its own death receptors DR4/5 changed the horizon of cancer research because TRAIL specifically kills cancer cells. (colinsbraincancer.com)
- PN9) would not be expected to demonstrate alterations in these apoptotic proteins since the Purkinje cells no longer demonstrate vulnerability to ethanol. (nih.gov)
- Of many epithelial, neuronal, and glial markers, we found that calcium-binding protein antibodies recognizing calretinin, calmodulin, or parvalbumin labeled immature hair cells in rat vestibular end organs. (jneurosci.org)
- The Servier compound - S63845 - targets a protein of the BCL2 family, called MCL1, which is essential for the sustained survival of these cancer cells. (edu.au)
- MCL1 is important for many cancers because it is a pro-survival protein that allows the cancerous cells to evade the process of programmed cell death that normally removes cancer cells from the body," Associate Professor Lessene said. (edu.au)
- Walter and Eliza Hall Institute researchers revealed the role of BCL-2 in cancer more than 28 years ago and the essential role of MCL1 for the survival of malignant cells four years ago. (edu.au)
- 5. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells. (nih.gov)
- Western-blot analysis showed an activation of proapoptotic factors including Fas (CD95), Fas-associated protein with death domain (FADD), caspase-8, death receptor 3 (DR3) and BID in apoptotic cells induced by metallic nickel particles. (cdc.gov)
- Apoptotic cell death induced by metallic nickel particles in JB6 cells is through a caspase-8/AIF mediated cytochrome c-independent pathway. (cdc.gov)
- Whereas TNFα preincubation leads to elevated levels of caspase-3 activity and cell death, pretreatment with IL-1β induces increased caspase-3 activity but keeps cells alive. (frontiersin.org)
- Techniques for visualizing cell death signaling in real-time in living cells has enhanced our understanding of these pathways. (nih.gov)
- Due to the rapid and active growth processes of tumor cells, cancer ranks second among the diseases that cause death worldwide [ 4 ]. (hindawi.com)
- We have reported that many insults can trigger cells to activate a cellular death pathway (Nature, 361:739-742, 1993), that several viruses encode proteins to block attempted cell suicide (Proc. (hopkinsmedicine.org)
- BCL-XL is involved in the survival of cancer cells. (neobiolab.com)
- In addition, in melanoma cells, TRIM17 favors cell survival and chemotherapy resistance by inhibiting TRIM28-mediated degradation of the anti-apoptotic and oncogenic protein BCL2A1. (cnrs.fr)
- Blocking autophagy degradation with chloroquine sensitised BCL-2HIGH cells to ABT-737-induced cell death, indicating that acquired autophagy acts as a cytoprotective mechanism in these cells. (bl.uk)
- It interacts with the E1B 19 kDa protein, which protects cells from virally-induced cell death. (nih.gov)
Receptors4
- Receptors that signal for cell death (death receptors) may have other non-apoptotic functions as well. (nih.gov)
- We believe it is mediated by excitotoxic cell death resulting from abnormalities in excitatory glutamatergic signal transduction pathways, including glutamate transporters and glutamate receptors as well as their downstream intracellular signaling molecules. (hopkinsmedicine.org)
- The multiple molecular variant forms of AFP are discussed in relation to published reports of AFP binding proteins and cell surface receptors. (atlasgeneticsoncology.org)
- AFP AA sequences are further presented as peptide identification sites for growth factors, receptors, cytoskeletal proteins, and chemokines. (atlasgeneticsoncology.org)
Family11
- Bcl-2 (B-cell leukemia 2) is an apoptotic protein and a member of the Bcl-2 family containing BH1-4 domains. (biolegend.com)
- The Bcl-2 protein forms homo- or hetero-dimers with other Bcl-2 family members. (biolegend.com)
- Furthermore, ethanol acts to prevent the reception of this trophic signaling resulting in the execution of the apoptotic pathway that includes specific alterations of proteins in the Bcl2 gene family. (nih.gov)
- MCL1 is a member of this protein family, and inhibiting it activates the process of programmed cell death. (edu.au)
- We use a multidisciplinary approach to study select pro-apoptotic BCL-2 family proteins. (yale.edu)
- Of particular interest to our group are the mechanisms by which Bcl-2 family proteins and other factors regulate programmed cell death , particularly in the nervous system, in cancer and in virus infections. (hopkinsmedicine.org)
- We have shown that anti-apoptotic Bcl-2 family proteins can be converted into killer molecules (Science 278:1966-8, 1997), that Bcl-2 family proteins interact with regulators of caspases and regulators of cell cycle check point activation (Molecular Cell 6:31-40, 2000). (hopkinsmedicine.org)
- Bcl-2 is a cytosolic protein and serves as an anti-apoptotic molecule, whereas another member of the family, Bax, functions as a pro-apoptotic protein ( 6 ). (spandidos-publications.com)
- 2013). This anti-apoptotic Bcl-2 family protein plays a critical role in the survival of a myriad of cell types and contributes to tumorigenesis and chemoresistance in a large number of cancers (Mojsa et al. (cnrs.fr)
- 2015). In addition, a series of studies on other TRIM17 partners led us to discribe a novel mode of action: TRIM17 can modulate the level of certain proteins by inhibiting other E3 ubiquitin-ligases of the TRIM family (Figure 1). (cnrs.fr)
- This gene is a member of the BCL2/adenovirus E1B 19 kd-interacting protein (BNIP) family. (nih.gov)
Overexpression1
- 12. Cyclin B1 overexpression induces cell death independent of mitotic arrest. (nih.gov)
Bcl21
- The encoded protein also interacts with E1B 19 kDa-like sequences of BCL2, another apoptotic protector. (nih.gov)
19971
- 94: 690-694, 1997), that cellular anti-death genes can alter the pathogenesis of virus infections (Nature Med. (hopkinsmedicine.org)
Kinase1
- In addition, activation of antiapoptotic factors including phospho-Akt (protein kinase B) and Bcl-2 was detected. (cdc.gov)
Therapeutic1
- The goal of the Katz Laboratory is to selectively control the cell death machinery for therapeutic benefit. (yale.edu)
Intracellular1
- C57BL/6 splenocytes intracellular stained with BCL/10C4 FITC. (biolegend.com)
Cleavage2
- Cleavage of Bcl-2 can convert to pro-apoptotic (by cleavage of BH4 domain). (biolegend.com)
- Communication between the pathways exists through cleavage of Bcl-2 interacting domain (Bid) by active caspase-8 to form truncated Bid (tBid). (cdc.gov)
Amino2
- The atlas further shows AFP as a protein consisting of multiple peptide-cassettes consisting of amino acid (AA) sequence stretches matched to peptide segments on prohormones and biological response modifier proteins. (atlasgeneticsoncology.org)
- Bcl-XL Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing amino acids 1-210.The Bcl-XL is expressed as GST-Tag fusion protein and purified by proprietary chromatographic techniques. (neobiolab.com)
Inhibitory3
- FLIP, Fas-associated death domain-like interleukin-1β converting enzyme-like inhibitory protein. (cdc.gov)
- 19. Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules. (nih.gov)
- Consequently, the inhibitory effect of EESP on STAT3 activation resulted in an increase in the pro-apoptotic Bax/Bcl-2 ratio, decrease in the expression of the pro-proliferative Cyclin D1 and CDK4, as well as down-regulation of pro-angiogenic VEGF-A and VEGFR-2 expression. (biomedcentral.com)
Regulation4
- These findings suggest that the regulation of caspase-3, Bcl-2 and Bax proteins may attenuate the cardiac damage occuring in myocardial infarction. (spandidos-publications.com)
- In recent years, we have been interested in the regulation of α-synuclein, a protein whose accumulation plays a crucial role in the death of dopaminergic neurons and the pathogenesis of Parkinson's disease. (cnrs.fr)
- Our current projects focus on this protein, notably the regulation of its expression in various models. (cnrs.fr)
- The BCL-2HIGH cell line Su-DHL4 showed up-regulation of more autophagy machinery genes at both the basal level and following starvation-induced autophagy compared with the BCL-2LOW cell line. (bl.uk)
Cytoskeletal1
- Additionally, in collaboration with colleagues, Dr. Tjandra is studying how the assembly of the cytoskeletal protein actin is regulated. (nih.gov)
Serine1
- A discussion follows in which peptide epitopes, extracellular matrix proteins, serine proteases, extracellular matrix, and cellular adhesion AA identity sites on AFP are considered. (atlasgeneticsoncology.org)
Cellular3
- The goal is to understand how protein-protein interactions involving CP can manage a relatively fast actin polymerization response to cellular stimuli. (nih.gov)
- His lab uses a number of unbiased approaches, including single cell and bulk RNA-Seq and proteomics, in both cell and animal models, as well as cellular imaging to understand how mutations affect protein function. (nih.gov)
- More specifically, they investigate the RNA-binding proteins and noncoding RNAs (lncRNAs, circRNAs, and microRNAs) that govern aging-relevant processes including cellular senescence, myogenesis, and the response to cell damage. (nih.gov)
Pathways2
Interact1
- During viral replication, these proteins assemble and interact with the host membrane to bud off forming infectious particles. (nih.gov)
Caspase3
- Furthermore, Path recruits the adaptor Fas-associated loss of life domain name (FADD) and procaspase-8 to create death-inducing signaling complexes (Disk), which leads to the activation from the initiator caspase-8, resulting in the activation of extrinsic and intrinsic apoptotic signaling downstream of caspase-3 (4,8). (colinsbraincancer.com)
- The treatment of hepatocytes with the BMDM supernatant, which contains both IL-1β and TNFα, sensitized to FasL-induced caspase-3 activation and cell death. (frontiersin.org)
- Furthermore, decreased protein levels of caspase-3 and Bax, and increased levels of Bcl-2 were observed in the infarcted hearts of the rats treated with various concentrations of HupA. (spandidos-publications.com)
Cytoplasm3
- Dr. Tjandra is studying how Bax transforms from a soluble protein in the cytoplasm to a membrane-associated protein that irreversibly promotes cell death. (nih.gov)
- Activation of Akt and Bcl-2 may play an important role in preventing cytochrome c release from mitochondria to the cytoplasm and may also be important in the carcinogenicity of metallic nickel particles. (cdc.gov)
- Phosphorylated STAT3 proteins in the cytoplasm dimerize and translocate to the nucleus where they regulate the expression of genes containing STAT3-binding sites in their promoters [ 12 ]. (biomedcentral.com)
Activation1
- Humanin selectively prevents the activation of pro-apoptotic protein BID by sequestering it into fibers. (nih.gov)
Gene2
- More specifically, we observed that auranofin orchestrates upregulation of the NOXA-encoding gene Phorbol-12-Myristate-13-Acetate-Induced Protein 1 ( PMAIP1 ) associated with chromatin remodeling and increased transcriptional accessibility. (nature.com)
- The hazard ratio (HR) for risk of death was 0.51 and statistically significant only when KRAS and BRAF wild-type pts were compared with pts harboring mutations in one gene. (biomedcentral.com)
Receptor2
- Las vitelogeninas son segregadas en la HEMOLINFA e incorporadas a los OVOCITOS por ENDOCITOSIS mediada por receptor, para formar las principales proteinas de la yema, las VITELINAS. (bvsalud.org)
- Vitellogenins are secreted into the HEMOLYMPH, and taken into the OOCYTES by receptor-mediated ENDOCYTOSIS to form the major yolk proteins, VITELLINS. (bvsalud.org)
Degradation1
- This post-translational modification can have various consequences on protein function, localization, interactions with partners or degradation by the proteasome. (cnrs.fr)
Ratio1
- We further compared the levels of pro-protein convertase, furin between samples having high and low proNGF: mature NGF ratio. (bvsalud.org)
Tumor1
- In order to investigate mechanisms of anti-tumor activity of cisplatin/Apo2L/TRAIL combination, we assessed in detail the molecular effects of cisplatin and Apo2L/TRAIL-activated cell death in two ovarian carcinoma cell lines, OVCAR3 and SKOV3, using cDNA array hybridization, Western blot and flow cytometry. (nih.gov)
Checkpoint1
- The checkpoint proteins p53 and ATM (ataxia telangiectasia mutated) are designed to block DNA replication of damaged DNA until repair of the DNA has been accomplished (Weinert, 1998), and ATM deficiency results in the lack of p53 induction by ionizing radiation, a DNA damaging agent (Barlow et al. (nih.gov)
Critical2
- One is the Bcl-2 protein Bax, which is a critical component in programmed cell death. (nih.gov)
- Like cell division and differentiation, cell death is also critical for normal development and maintenance of healthy tissues. (hopkinsmedicine.org)
Survival3
- BH3 mimetics inhibit a group of proteins known as the 'pro-survival BCL-2 proteins'," he said. (edu.au)
- Bcl-xL has cell death repressor activity and therefore acts as a survival protein. (neobiolab.com)
- High levels of BCL-2 and active autophagy did not affect the clinical outcome of FL, but significantly shortened the survival rates of DLBCL patients. (bl.uk)
Genes1
- In particular, more autophagy machinery genes showed significantly increased expression in both purified and un-purified FL samples, indicating that despite frequently overexpressing BCL-2, FL appears to have increased basal level autophagy activity. (bl.uk)
Regulate2
- Bcl-2 has been reported to regulate cell cycle progression via ROS. (biolegend.com)
- For more than 15 years, our team has been interested in the molecular mechanisms that regulate cell death in neurons. (cnrs.fr)
Induction2
- Synergistic activity of these drugs resulted from auranofin-mediated upregulation of NOXA pro-apoptotic protein and potent induction of apoptotic cell death. (nature.com)
- Autophagy can be inhibited by the anti-apoptotic protein BCL-2 which binds and sequesters the autophagy essential protein Beclin-1, therefore preventing autophagy induction. (bl.uk)
Suppression1
- Implicated in the suppression of cell death. (nih.gov)
Defective1
- Defective cell death programs cause disease states. (hopkinsmedicine.org)
Domain1
- TRIM proteins represent one of the largest classes of E3 ubiquitin-ligases with a RING domain. (cnrs.fr)
Cancer2
- Cancer is one of the important causes of death worldwide. (hindawi.com)
- Insufficient cell death underlies human cancer and autoimmune disease, while excessive cell death underlies human neurological disorders and aging. (hopkinsmedicine.org)
Trigger1
- Emma examined the ability of a library of synthetic isothiocyanates to inhibit the pro-inflammatory cytokine MIF, and to trigger apoptotic cell death. (otago.ac.nz)
Complexes1
- In particular, he wants to improve the ability of NMR to study protein complexes in their proper context, i.e. as part of multi-component systems in complex lipid environments. (nih.gov)
Suggests1
- This work also suggests that calcium-binding proteins are useful markers for studies on inner ear hair cell differentiation and regeneration. (jneurosci.org)
Heterogeneous1
- DLBCL samples (n=109) showed a heterogeneous expression pattern of these four proteins. (bl.uk)